Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Inventory Average: 2023-2025

Historic Inventory Average for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to $5.9 million.

  • Tonix Pharmaceuticals Holding's Inventory Average fell 32.63% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 32.63%. This contributed to the annual value of $11.0 million for FY2024, which is N/A change from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Inventory Average stood at $5.9 million for Q3 2025, which was down 17.04% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Inventory Average ranged from a high of $13.5 million in Q3 2023 and a low of $5.9 million during Q3 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Inventory Average value was $8.7 million (recorded in 2024), while the average stood at $9.9 million.
  • Data for Tonix Pharmaceuticals Holding's Inventory Average shows a maximum YoY crashed of 39.43% (in 2024) over the last 5 years.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Inventory Average (Quarterly) stood at $13.5 million in 2023, then slumped by 39.43% to $8.2 million in 2024, then tumbled by 32.63% to $5.9 million in 2025.
  • Its last three reported values are $5.9 million in Q3 2025, $7.1 million for Q2 2025, and $8.3 million during Q1 2025.